In Vitro Diagnostics (IVD)
Quality Control Market
In Vitro Diagnostics (IVD) Quality Control Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
In Vitro Diagnostics (IVD) Quality Control Market Size and Growth
The In Vitro Diagnostics (IVD) Quality Control market is expanding rapidly, driven by increasing demand for accurate diagnostic testing. As of 2023, the market size is estimated to reach approximately $1.5 billion. Key trends include advancements in technology and regulatory compliance, which enhance the reliability and safety of diagnostic procedures. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Siemens Healthcare GmbH
◍ Roche Diagnostics
◍ Abbott
◍ Abbott Laboratories Inc.
◍ Bio-Techne
◍ Hologic Inc.
◍ Qiagen N.V.
◍ Bio-Rad Laboratories Inc.
◍ Quidel Corporation
◍ Becton
◍ Dickinson and Company(BD)
◍ BioMerieux Inc.
◍ Sysmex Corporation
◍ Sero AS
◍ Thermo Fisher Scientific Inc.
The In Vitro Diagnostics (IVD) Quality Control Market features companies like Siemens, Roche, Abbott, BioRad, and Thermo Fisher, enhancing market growth through innovative QC products and solutions. These companies drive advancements in testing accuracy and reliability, fostering confidence in diagnostics. Select sales revenues include: Roche - €63 billion; Abbott - $43 billion. Request Sample Report
Market Segmentation
By Application
By Product
Quality Controls
Data Management
Quality Assurance Services ◍ Clinical Chemistry ◍ Immunochemistry
◍ Hematology
◍ Molecular Diagnostics
◍ Coagulation
◍ Microbiology
◍ Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
